Trial Profile
Add-on ivabradine in patients with severe systolic chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2012
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Chronic heart failure; Ventricular dysfunction
- Focus Therapeutic Use
- 09 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.